Results 71 to 80 of about 3,192 (113)

Linvoseltamab versus real-world International Myeloma Working Group standard-of-care in triple-class exposed relapsed/refractory multiple myeloma. [PDF]

open access: yesBlood Cancer J
Kumar S   +42 more
europepmc   +1 more source

Prognostic factors of survival in second allogeneic hematopoietic transplantation. [PDF]

open access: yesAnn Hematol
Cantera Estefanía R   +19 more
europepmc   +1 more source

Comparative Efficacy of Talquetamab vs. Real-World Physician's Choice of Treatment in Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma: Updated Analyses of MonumenTAL-1 vs. LocoMMotion/MoMMent. [PDF]

open access: yesAdv Ther
Einsele H   +35 more
europepmc   +1 more source

Post-surgical brachytherapy in the treatment of keloids: A single-center study. [PDF]

open access: yesJ Contemp Brachytherapy
Gonzalez-Alaña I   +8 more
europepmc   +1 more source

[Occupational balance, disability and functionality in people with rheumatic disease]. [PDF]

open access: yesAn Sist Sanit Navar, 2023
Martín Pérez AM   +4 more
europepmc   +1 more source

[More than playing: The therapeutic value of play in comprehensive childcare from primary care]. [PDF]

open access: yesAten Primaria
González-Díaz A   +3 more
europepmc   +1 more source

[Determinants of access to dental health in Spain]. [PDF]

open access: yesAten Primaria
Ruiz-Campo S   +2 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy